---
figid: PMC9264050__jtd-14-06-2089-f5
pmcid: PMC9264050
image_filename: jtd-14-06-2089-f5.jpg
figure_link: /pmc/articles/PMC9264050/figure/f5/
number: Figure 5
figure_title: ''
caption: Pirfenidone inhibits RLE-6TN fibrosis by targeting the TNF-α/STAT3/KL6 signaling
  pathway. TNF-α, tumor necrosis factor-α; STAT3, signal transducer and activator
  of transcription 3; KL-6, Krebs Von den Lungen-6.
article_title: Pirfenidone inhibits cell fibrosis in connective tissue disease-associated
  interstitial lung disease by targeting the TNF-α/STAT3/KL6 pathway.
citation: Yanhua Zuo, et al. J Thorac Dis. 2022 Jun;14(6):2089-2102.
year: '2022'

doi: 10.21037/jtd-22-41
journal_title: Journal of Thoracic Disease
journal_nlm_ta: J Thorac Dis
publisher_name: AME Publishing Company

keywords:
- Pirfenidone
- connective tissue disease-associated interstitial lung disease (CTD-ILD)
- tumor necrosis factor-α (TNF-α)
- signal transducer and activator of transcription 3 (STAT3)
- Krebs Von den Lungen-6 (KL-6)

---
